🇺🇸 Aclasta in United States
12,211 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 12,211
Most-reported reactions
- Death — 2,784 reports (22.8%)
- Fall — 1,616 reports (13.23%)
- Pain — 1,502 reports (12.3%)
- Pyrexia — 1,170 reports (9.58%)
- Arthralgia — 1,104 reports (9.04%)
- Malaise — 1,101 reports (9.02%)
- Pain In Extremity — 839 reports (6.87%)
- Nausea — 731 reports (5.99%)
- Headache — 687 reports (5.63%)
- Fatigue — 677 reports (5.54%)
Aclasta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Aclasta approved in United States?
Aclasta does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Aclasta in United States?
Mel Shiuann-Sheng Lee is the originator. The local marketing authorisation holder may differ — check the official source linked above.